BridgeMD
Tests treatment safety and results for Emotional Disorders
Official title Effectiveness of the Group Unified Protocol for Emotional Disorders in Adults in a Public Mental Health Setting
ClinicalTrials.gov ID: NCT07682064
What this study is testing
- What it's testing
- This study has three primary objectives: 1. To adapt the Spanish version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP; Barlow et al., 2011, 2019a, 2019b) for delivery in a group format within the Spanish Public Mental Health System for adults diagnosed with emotional disorders.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged 18 to 65 years.
- Ability and willingness to provide written informed consent.
- Sufficient proficiency in Spanish to participate in the intervention and complete study assessments.
- Sufficient cognitive capacity to understand the intervention content.
- A primary diagnosis of an emotional disorder with mild, moderate, or severe symptom severity, including Depressive Disorders, Anxiety Disorders...
You likely can't join if
- Refusal to provide informed consent or withdrawal of consent during the study.
- Current severe substance use disorder or behavioral addiction.
- Current high suicide risk.
- Current psychotic symptoms or psychotic disorder.
- Neurological disorders or severe medical conditions that could interfere with participation in or adherence to the intervention.
- Intellectual disability, significant language difficulties, or any other condition that may impair the participant's ability to understand the...
See the full eligibility criteria
- Aged 18 to 65 years.
- Ability and willingness to provide written informed consent.
- Sufficient proficiency in Spanish to participate in the intervention and complete study assessments.
- Sufficient cognitive capacity to understand the intervention content.
- A primary diagnosis of an emotional disorder with mild, moderate, or severe symptom severity, including Depressive Disorders, Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma and Stressor-Related...
- Presence of emotional symptoms (e.g., anxiety, depressive, or phobic symptoms), somatic symptoms, obsessive symptoms, and/or avoidance behaviors associated with clinically significant impairment, as indicated by...
- Refusal to provide informed consent or withdrawal of consent during the study.
- Current severe substance use disorder or behavioral addiction.
- Current high suicide risk.
- Current psychotic symptoms or psychotic disorder.
- Neurological disorders or severe medical conditions that could interfere with participation in or adherence to the intervention.
- Intellectual disability, significant language difficulties, or any other condition that may impair the participant's ability to understand the intervention content.
The study team makes the final eligibility decision.
Where it's taking place
- Logroño, La Rioja, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Logroño, La Rioja, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.